Raymond James Initiates Strong Buy on Amplitude with $10 Target
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 49 minutes ago
0mins
Source: seekingalpha
- Coverage Initiation: Raymond James has initiated coverage on AI analytics firm Amplitude (AMPL) with a Strong Buy rating and a $10 price target, reflecting confidence in its future growth potential.
- Growth Acceleration Outlook: Analysts noted that Amplitude is entering a multi-year growth acceleration phase, expected to achieve strong incremental margin expansion that should drive valuation multiple expansion, indicating optimistic market expectations for its performance.
- Revenue Forecast: Amplitude forecasts FY2026 revenue between $397 million and $403 million, indicating the addition of $16 million in incremental ARR from its partnership with Statsig, further enhancing its financial outlook.
- Market Confidence Boost: With the analysts' positive rating and upward revenue expectations, market confidence in Amplitude has significantly increased, potentially attracting more investor attention and driving stock price appreciation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AMPL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AMPL
Wall Street analysts forecast AMPL stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 7.650
Low
12.00
Averages
14.25
High
16.00
Current: 7.650
Low
12.00
Averages
14.25
High
16.00
About AMPL
Amplitude, Inc. provides a digital analytics platform that helps companies unlock the power of their products. The Company’s Digital Analytics Platform helps businesses understand how people are using their products so they can build digital experiences. Its platform comprises several primary offerings: Amplitude Analytics, Amplitude Session Replay, Amplitude Feature Experimentation, Amplitude Web Experimentation, Amplitude Activation and Amplitude Guides and Surveys. Amplitude Analytics is the cornerstone of the platform and provides real-time insights into user behavior. Amplitude Activation unifies data across multiple sources, creating a single, enriched dataset that fuels analytics and personalization. Amplitude Guides and Surveys helps companies to deploy in-product guides, tours, and surveys, using the power of behavioral insights to fuel great results. The Company's portfolio includes InfiniGrow, which is an AI marketing analytics platform.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Raymond James Initiates Strong Buy on Amplitude with $10 Target
- Coverage Initiation: Raymond James has initiated coverage on AI analytics firm Amplitude (AMPL) with a Strong Buy rating and a $10 price target, reflecting confidence in its future growth potential.
- Growth Acceleration Outlook: Analysts noted that Amplitude is entering a multi-year growth acceleration phase, expected to achieve strong incremental margin expansion that should drive valuation multiple expansion, indicating optimistic market expectations for its performance.
- Revenue Forecast: Amplitude forecasts FY2026 revenue between $397 million and $403 million, indicating the addition of $16 million in incremental ARR from its partnership with Statsig, further enhancing its financial outlook.
- Market Confidence Boost: With the analysts' positive rating and upward revenue expectations, market confidence in Amplitude has significantly increased, potentially attracting more investor attention and driving stock price appreciation.
See More
Latest Wall Street Rating Updates
- Abbott Labs Upgrade: Baird initiates coverage on Abbott Labs (ABT) with an outperform rating, projecting steady revenue and earnings growth of 6-8% over the next few years, bolstered by its leading position in the rapidly growing MedDevice market, enhancing the company's competitive edge.
- Murphy USA Upgrade: Jefferies upgrades Murphy USA (MUSA) from hold to buy, citing improving fuel margins that are expected to drive EBITDA outlook significantly higher by 20-25%, which will materially enhance the company's financial performance in the coming years.
- Abivax Upgrade: Jefferies raises Abivax (ABVX) to buy, noting strong data for its ulcerative colitis drug that alleviates key market concerns, which is likely to drive a rebound in the stock price.
- Talos Energy Upgrade: Roth upgrades Talos Energy (TALO) from neutral to buy, raising the price target by 6% to $17, based on its robust balance sheet and low production decline rates, indicating strong future growth potential.
See More
Amplitude CTO Sells Shares Amid Market Pressure, Retains Significant Stake
- Executive Stock Sale: Amplitude's CTO Curtis Liu sold 22,201 shares on June 1, 2026, for approximately $178,000, indicating a non-discretionary decision amid current market pressures.
- Holding Percentage Change: This transaction represented 2.16% of Liu's direct holdings, leaving him with 1,004,779 shares, reflecting a 9.3% reduction since March 2026, suggesting a cautious outlook on the company's future.
- Transaction Plan Context: The stock sale was executed under a 10b5-1 trading plan adopted on November 26, 2025, indicating it was non-discretionary and aimed at avoiding insider trading allegations, thereby enhancing market transparency.
- Market Performance Analysis: Despite Liu's stock sale, Amplitude reported $93.5 million in sales for Q1 2026, a 17% year-over-year increase, with projected revenue for 2026 expected to reach between $397 million and $403 million, demonstrating resilience in its analytics business amid AI competition.
See More
Amplitude Under Investigation for Securities Fraud Claims
- Guidance Reduction: On May 6, 2026, Amplitude announced a significant reduction in its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability.
- Stock Price Reaction: Following the guidance revision, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, reflecting investor concerns regarding the company's future profitability.
- Analyst Downgrade: Bank of America downgraded Amplitude due to concerns about rising execution risks and a weaker profitability outlook linked to its partnership strategy and increasing AI-related costs, suggesting potential margin compression.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its officers have engaged in securities fraud or other unlawful business practices, advising investors to contact the firm for information on joining the class action.
See More
Amplitude Under Investigation Amid 21.41% Stock Drop Following Guidance Cut
- Guidance Revision: On May 6, 2026, Amplitude announced a reduction in its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability that could undermine investor confidence.
- Analyst Downgrade: Bank of America downgraded Amplitude due to concerns over rising execution risks and a weaker profitability outlook linked to its partnership strategy and increasing AI-related costs, reflecting a market sentiment that may diminish investor trust in the company's future performance.
- Stock Price Decline: Following the announcement, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, a significant drop that could trigger further investor scrutiny and impact the company's market reputation.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its executives have engaged in securities fraud or other unlawful business practices, which may exacerbate market unease and affect shareholder trust and investment decisions.
See More
Pomerantz Investigates Amplitude for Securities Fraud Claims
- Guidance Revision: On May 6, 2026, Amplitude lowered its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability.
- Stock Price Reaction: Following the guidance adjustment, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, reflecting investor concerns regarding the company's future profitability.
- Analyst Downgrade: Bank of America downgraded Amplitude due to rising execution risks and concerns over profitability linked to its partnership strategy and increasing AI-related costs, exacerbating market skepticism about its financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its executives engaged in securities fraud or other unlawful business practices, potentially exposing the company to class action lawsuits that could impact its reputation and future financing capabilities.
See More
Raymond James Initiates Strong Buy on Amplitude with $10 Target
- Coverage Initiation: Raymond James has initiated coverage on AI analytics firm Amplitude (AMPL) with a Strong Buy rating and a $10 price target, reflecting confidence in its future growth potential.
- Growth Acceleration Outlook: Analysts noted that Amplitude is entering a multi-year growth acceleration phase, expected to achieve strong incremental margin expansion that should drive valuation multiple expansion, indicating optimistic market expectations for its performance.
- Revenue Forecast: Amplitude forecasts FY2026 revenue between $397 million and $403 million, indicating the addition of $16 million in incremental ARR from its partnership with Statsig, further enhancing its financial outlook.
- Market Confidence Boost: With the analysts' positive rating and upward revenue expectations, market confidence in Amplitude has significantly increased, potentially attracting more investor attention and driving stock price appreciation.
See More
Latest Wall Street Rating Updates
- Abbott Labs Upgrade: Baird initiates coverage on Abbott Labs (ABT) with an outperform rating, projecting steady revenue and earnings growth of 6-8% over the next few years, bolstered by its leading position in the rapidly growing MedDevice market, enhancing the company's competitive edge.
- Murphy USA Upgrade: Jefferies upgrades Murphy USA (MUSA) from hold to buy, citing improving fuel margins that are expected to drive EBITDA outlook significantly higher by 20-25%, which will materially enhance the company's financial performance in the coming years.
- Abivax Upgrade: Jefferies raises Abivax (ABVX) to buy, noting strong data for its ulcerative colitis drug that alleviates key market concerns, which is likely to drive a rebound in the stock price.
- Talos Energy Upgrade: Roth upgrades Talos Energy (TALO) from neutral to buy, raising the price target by 6% to $17, based on its robust balance sheet and low production decline rates, indicating strong future growth potential.
See More
Amplitude CTO Sells Shares Amid Market Pressure, Retains Significant Stake
- Executive Stock Sale: Amplitude's CTO Curtis Liu sold 22,201 shares on June 1, 2026, for approximately $178,000, indicating a non-discretionary decision amid current market pressures.
- Holding Percentage Change: This transaction represented 2.16% of Liu's direct holdings, leaving him with 1,004,779 shares, reflecting a 9.3% reduction since March 2026, suggesting a cautious outlook on the company's future.
- Transaction Plan Context: The stock sale was executed under a 10b5-1 trading plan adopted on November 26, 2025, indicating it was non-discretionary and aimed at avoiding insider trading allegations, thereby enhancing market transparency.
- Market Performance Analysis: Despite Liu's stock sale, Amplitude reported $93.5 million in sales for Q1 2026, a 17% year-over-year increase, with projected revenue for 2026 expected to reach between $397 million and $403 million, demonstrating resilience in its analytics business amid AI competition.
See More
Amplitude Under Investigation for Securities Fraud Claims
- Guidance Reduction: On May 6, 2026, Amplitude announced a significant reduction in its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability.
- Stock Price Reaction: Following the guidance revision, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, reflecting investor concerns regarding the company's future profitability.
- Analyst Downgrade: Bank of America downgraded Amplitude due to concerns about rising execution risks and a weaker profitability outlook linked to its partnership strategy and increasing AI-related costs, suggesting potential margin compression.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its officers have engaged in securities fraud or other unlawful business practices, advising investors to contact the firm for information on joining the class action.
See More
Amplitude Under Investigation Amid 21.41% Stock Drop Following Guidance Cut
- Guidance Revision: On May 6, 2026, Amplitude announced a reduction in its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability that could undermine investor confidence.
- Analyst Downgrade: Bank of America downgraded Amplitude due to concerns over rising execution risks and a weaker profitability outlook linked to its partnership strategy and increasing AI-related costs, reflecting a market sentiment that may diminish investor trust in the company's future performance.
- Stock Price Decline: Following the announcement, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, a significant drop that could trigger further investor scrutiny and impact the company's market reputation.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its executives have engaged in securities fraud or other unlawful business practices, which may exacerbate market unease and affect shareholder trust and investment decisions.
See More
Pomerantz Investigates Amplitude for Securities Fraud Claims
- Guidance Revision: On May 6, 2026, Amplitude lowered its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability.
- Stock Price Reaction: Following the guidance adjustment, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, reflecting investor concerns regarding the company's future profitability.
- Analyst Downgrade: Bank of America downgraded Amplitude due to rising execution risks and concerns over profitability linked to its partnership strategy and increasing AI-related costs, exacerbating market skepticism about its financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its executives engaged in securities fraud or other unlawful business practices, potentially exposing the company to class action lawsuits that could impact its reputation and future financing capabilities.
See More
